PRECLINICAL VALIDATION OF NOVEL COMBINATION THERAPEUTIC STRATEGIES TARGETING KRAS AND BRAF MUTATED COLORECTAL CANCER FOR NEAR-TERM CLINICAL EXAMINATION

Baylor College Of Medicine, Houston TX

Investigators